Literature DB >> 30074457

Evaluation of an in vivo model for ventricular shunt infection: a pilot study using a novel antimicrobial-loaded polymer.

Rajiv R Iyer1, Noah Gorelick1, Karen Carroll2, Ari M Blitz3, Sarah Beck4, Caroline M Garrett4, Audrey Monroe1, Betty Tyler1, Sean T Zuckerman5, Jeffrey R Capadona5,6, Horst A von Recum5, Mark G Luciano1.   

Abstract

OBJECTIVE: Ventricular shunt infection remains an issue leading to high patient morbidity and cost, warranting further investigation. The authors sought to create an animal model of shunt infection that could be used to evaluate possible catheter modifications and innovations.
METHODS: Three dogs underwent bilateral ventricular catheter implantation and inoculation with methicillin-sensitive Staphylococcus aureus (S. aureus). In 2 experimental animals, the catheters were modified with a polymer containing chemical "pockets" loaded with vancomycin. In 1 control animal, the catheters were polymer coated but without antibiotics. Animals were monitored for 9 to 11 days, after which the shunts were explanted. MRI was performed after shunt implantation and prior to catheter harvest. The catheters were sonicated prior to microbiological culture and also evaluated by electron microscopy. The animals' brains were evaluated for histopathology.
RESULTS: All animals underwent successful catheter implantation. The animals developed superficial wound infections, but no neurological deficits. Imaging demonstrated ventriculitis and cerebral edema. Harvested catheters from the control animal demonstrated > 104 colony-forming units (CFUs) of S. aureus. In the first experimental animal, one shunt demonstrated > 104 CFUs of S. aureus, but the other demonstrated no growth. In the second experimental animal, one catheter demonstrated no growth, and the other grew trace S. aureus. Brain histopathology revealed acute inflammation and ventriculitis in all animals, which was more severe in the control.
CONCLUSIONS: The authors evaluated an animal model of ventricular shunting and reliably induced features of shunt infection that could be microbiologically quantified. With this model, investigation of pathophysiological and imaging correlates of infection and potentially beneficial shunt catheter modifications is possible.

Entities:  

Keywords:  AIC = antibiotic-impregnated catheter; CFU = colony-forming unit; Staphylococcus aureus; antibiotics; catheter; coating; cyclodextrin; hydrocephalus; infection; polymer; shunt; vancomycin; ventriculitis

Mesh:

Substances:

Year:  2018        PMID: 30074457      PMCID: PMC6677638          DOI: 10.3171/2018.1.JNS172523

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  45 in total

1.  Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus.

Authors:  Daniel M Sciubba; R Morgan Stuart; Matthew J McGirt; Graeme F Woodworth; Amer Samdani; Benjamin Carson; George I Jallo
Journal:  J Neurosurg       Date:  2005-08       Impact factor: 5.115

2.  Reduction in CSF shunt infection over a 10-year period associated with the application of concentrated topical antibiotic powder directly to surgical wounds prior to closure.

Authors:  Joshua M Beckman; Ernest K Amankwah; Lisa L Tetreault; Gerald F Tuite
Journal:  J Neurosurg Pediatr       Date:  2015-09-18       Impact factor: 2.375

Review 3.  Antimicrobial-impregnated and -coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis.

Authors:  Athanasios A Konstantelias; Konstantinos Z Vardakas; Konstantinos A Polyzos; Giannoula S Tansarli; Matthew E Falagas
Journal:  J Neurosurg       Date:  2015-03-13       Impact factor: 5.115

4.  CSF shunt infections in children.

Authors:  U Kontny; B Höfling; P Gutjahr; D Voth; M Schwarz; H J Schmitt
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

Review 5.  Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts: a systematic review.

Authors:  Bernardo Ratilal; João Costa; Cristina Sampaio
Journal:  J Neurosurg Pediatr       Date:  2008-01       Impact factor: 2.375

6.  Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article.

Authors:  Tamara D Simon; Matthew Hall; Jay Riva-Cambrin; J Elaine Albert; Howard E Jeffries; Bonnie Lafleur; J Michael Dean; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2009-08       Impact factor: 2.375

7.  Thermomechanical Properties, Antibiotic Release, and Bioactivity of a Sterilized Cyclodextrin Drug Delivery System.

Authors:  Jeffrey M Halpern; Catherine A Gormley; Melissa Keech; Horst A von Recum
Journal:  J Mater Chem B       Date:  2014-05-14       Impact factor: 6.331

8.  A no-touch technique protocol to diminish cerebrospinal fluid shunt infection.

Authors:  W J Faillace
Journal:  Surg Neurol       Date:  1995-04

9.  Gram-negative cerebrospinal fluid shunt-associated infections.

Authors:  C J Sells; D B Shurtleff; J D Loeser
Journal:  Pediatrics       Date:  1977-04       Impact factor: 7.124

10.  Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children.

Authors:  Peter Kan; John Kestle
Journal:  Childs Nerv Syst       Date:  2007-02-07       Impact factor: 1.532

View more
  1 in total

1.  The Sheep as a Comprehensive Animal Model to Investigate Interdependent Physiological Pressure Propagation and Multiparameter Influence on Cerebrospinal Fluid Dynamics.

Authors:  Nina Eva Trimmel; Anthony Podgoršak; Markus Florian Oertel; Simone Jucker; Margarete Arras; Marianne Schmid Daners; Miriam Weisskopf
Journal:  Front Neurosci       Date:  2022-03-31       Impact factor: 4.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.